with any confidence whether or not two products differ in their performance.
Finally, it must be admitted that strict adherence to this scheme will involve a considerable amount of work. It may not always be possible for reasons of economy, staff, or time for an evaluator to complete it all. In this case his report must inevitably fall further short of the ideal than would otherwise be the case, but he must use his scientific judgement about which parts of the scheme are less useful for his purpose.
General introduction
Recent years have seen a big increase in the number and variety of diagnostic kits available commercially to the clinical laboratory. The increasing number of tests that are infrequently required makes these kits attractive to laboratories of all sizes who are able, thereby, to offer a wide range of determinations to the clinician with a minimum of effort. A further advantage of the kit is that if a number of laboratories use the same product, their results are likely to be more nearly in agreement than might otherwise be the case. However, the very fact that kits are most Definition of terms useful for the less common tests, and also in the emergency situation, means that the quality of the The definitions of the terms used in this scheme laboratory's service is very dependent upon the follow those in various recommendations of the quality and consistency of the kit itself. In addition, International Federation of Clinical Chemistry the cost of these products is relatively high, and it (IFCC). In particular, a kit, for the purpose of this behoves the analyst to ensure that he is getting value scheme, is defined, following that in the IFCC profor money and to know how much of his normal posals on the labelling of clinical laboratory materials quality-control procedures may safely be left to the (IFCC, 1976) , as 'a collection of all, or substantially manufacturer of the kit.
all, of the chemical substances required to analyse a Although analysts do frequently carry out evalua-fluid, or other material, for one or more of its suptions of the kits they intend to use, these evaluations posed constituents, packaged together with working are done in their own individual way so that it instructions on how to use those substances to becomes very difficult to compare results on different complete the analysis and arrive at a result'. It may products evaluated by different analysts. In this be assumed that where the kit will generally be used document a standard procedure is suggested, which in laboratory conditions, equipment and materials will, iffollowed generally, result in evaluation reports which are normally available (such as distilled water) that would enable comparisons to be made. Thus the may have to be provided by the user. profession may benefit from its accumulated Following the IFCC provisional recommendations knowledge in a way that has not hitherto been on quality control (Buttner et al., 1975) , the words possible.
imprecision and inaccuracy will be used when a In order to facilitate the reliable comparison of numerical measure is given to the variability within two or more products, considerable emphasis will be a set of replicate measurements and to the deviation placed on the correct statistical evaluation of the of a measurement from the true value, respectively. results and, in particular, on the derivation of the The terms precision and accuracy will be used as confidence limits within which estimates of the general terms indicating the agreement between various statistical parameters may be said to lie. replicates and the agreement of a measured value Only when these limits are given is it possible to say with the true or most probable value. 136
In conformity with general usage, the word linear will be used in place of the formally more correct word rectilinear to indicate that the points on a graph fall on a straight line. The word linearity is used in a general sense to indicate the form of the relationship between the analytical result and the true result. The word stability is used for the period of time over which the analytical system will produce acceptable results and will have units of time (months, days, hours, etc) .
The significance of results is assessed statistically. Differences will be deemed to be significant when the statistical chance that there is a real difference exceeds 95 %(that is, P < 0'05). Similarly, confidence limits are those limits inside of which there is a 95 % chance that the true result lies.
This scheme is intended primarily for the clinical biochemistry laboratory. However, it is hoped that it may also prove useful in other analytical laboratories.
It must be emphasised that an evaluation can apply only to the actual kits evaluated. All analysts using kits routinely must satisfy themselves that a new batch of kits give results comparable with the old batch. Changes in formulation or the values of standards are not unknown.
Scope of this scheme
This scheme of evaluation is divided into three main sections:
An examination of the contents of the kit and the manufacturer's claims for its performance. 2 The testing of the kit in terms of its precision, accuracy, linearity, specificity, or stability. 3 Comments and conclusions based on an assessment of this examination and testing, including an assessment of the clinical usefulness of the kit. 4 A final section contains all the essential and relevant statistical equations. Sections 1 and 3 above may be applied to all kits, but section 2 applies mainly to kits giving quantitative results. Testing of qualitative systems will be discussed in general terms only.
Evaluation
During the evaluation of a kit it is important that the manufacturer's instructions are followed exactly. If for any reason this is impossible, any changes in procedure must be described in detail. It is always important to state what equipment was used during the analytical work. The methods which follow are not intended to be suitable for a detailed testing of 137 all aspects of an analytical method but to assess how well a complete method works in practice.
EXAMINATION OF KIT
An evaluation should begin with an examination of the kit itself and the information supplied with it by the manufacturer. The labelling should be examined to ascertain whether or not it complies with the IFCC (1976) recommendations.
The evaluation report should give the reader the following information concerning the kit and its manufacturer.
1 The name of the kit. 2 The name and address of the manufacturer and of the agent or distributor from whom the kit was obtained. 3 The substance which is measured by the kit (the analyte), and the source fluid for which it may be used (for example, serum, urine, etc). 4 Thenatureof the analytical process (for example, dip-stick, kinetic, colorimetric, agglutination, etc), the chemical process involved, and whether the results are quantitative or qualitative. 5 The sizes of kits available and their cost (with a date). Sizes should be given in terms of the volume of complete working reagent except in certain specified cases (see 6 below). In the case of dried liquid reagents, the minimum volume that must be reconstituted should be indicated. For example, if the kit provides four bottles, each of which produces 25 ml of working reagent, the size should be quoted as 4 x 25 ml rather than as 100 ml, The cost should include the cost of any materials not included in the kit but which are required to reconstitute the working reagent. 6 In certain cases, the size of the kit may be specified more usefully than as in (5) by giving the number of tests that can be carried out.
Examples are test strips, slide tests, and similar systems, and specification in terms of the number of tests should be restricted to kits of this type. 7 The size(s) of the kites) actually evaluated and the manufacturer's lot number(s). 8 The number of different bottles or solutions that are involved in reconstituting the working reagent. Indication should also be given of the manipulations involved so that the reader can assess the convenience in use. 9 Any reagents, including water, that are required and that are not contained in the kit. The cost of these should be included under (5) above. 10 Any ancillary equipment or instruments that are needed to use the kit.
11 Any substances that are known to interfere with the analytical accuracy of the kit. 12 Any hazards involved in the handling or use of the kit. Any hazardous reagents should be packaged in such a way as to minimise the dangers of spillage during the opening of the vials. 13 The stability of the kit and of the reconstituted reagents. The former should be given as the period between receipt of the kit and its expiry date, the latter as the period after reconstitution during which the manufacturer states that the solutions are usable. 14 The storage conditions recommended for both the kit and the reconstituted reagents (it is helpful if the physical size of the boxes is given, especially if refrigeration is required). 15 Some indication of the range of results to be expected from a normal population. This should not be construed as a reference range but as an indication to a potential user of the scale to be expected. 16 A statement of whether or not the labelling conforms with the IFCC (1976) recommendations, and whether or not all the above information was readily available from the labels, package inserts, or manufacturer's advertising literature. In addition to the above information the evaluation report should include as much of the following information as the manufacturer provides.
1 The range of analyte concentrations for which the kit is suitable. 2 The precision with which the manufacturer claims that results may be obtained. Since the precision of an assay is very dependent upon the equipment used and the skill and technique of the operator, the information should include a statement of the equipment that was used. Such manufacturer's data must be interpreted with care because of the effect of the operator and the equipment on the apparent performance. Imprecision is best quoted in terms of a coefficient of variation at stated levels. 3 The accuracy to be expected in relation to some established or recognised technique. Results of recovery experiments may also be given but are not of themselves adequate expressions of accuracy. If no established or recognised technique exists, then where possible the relationship between the results obtained and any national or international standard should be given.
4 If the method depends upon absolute calibration (for example, the molar absorbance of NADH, cyanmethaemoglobin, etc) or on singlepoint calibration, the maximum deviation of the actual response from the calibration line within the range of the kit should be given.
METHODS
This section describes recommended methods for estimating the imprecision, inaccuracy (and hence any deviations from linearity), and stability as applied to quantitative tests. Suggestions for qualitative tests are described on page 140. When two or more kits are being assessed together, they should as far as possible be run in a random sequence throughout the evaluation.
Precision
There are three situations for which a measure of the imprecision of the method is needed. 1 Within a single batch of assays. This will be referred to as the within-batch imprecision. Except in the case of kits designed for single tests, the withinbatch imprecision has little direct relevance to the kit itself. It is a measure ot the variability of the instrumentation and the operator, but this information is needed in the assessment of other parts of the evaluation. When the kit is designed for single tests a slightly different procedure must be used to try to distinguish variability due to the kit from that due to the instrumentation (see below).
2 Over a number of different batches of assays, but using the same reagents. This will be referred to as the between-batch imprecision and will reflect variations caused by variability of standards, instrument settings, and so on, but not chemical variability between kits. These results are relevant to the kit because they involve the ability from batch to batch to reproduce results relative to that of a standard or set of standards. In many cases it may be impracticable to assess this form of imprecision, and it will often be combined with between-kit studies (see below).
3 Over a number of different batches of assays using different sets of reagents. This is the overall between-batch imprecision, which would normally be determined in routine use by normal qualitycontrol procedures. This variability would ideally include many different batches of kits (manufacturer's batches), but it will often be impracticable to include this in an evaluation although, in many ways, it is the most crucial test of the kit's suitability for routine use. In the following recommended methods no distinction will be made between the imprecision described in (2) and (3). It must be decided in the individual case whether or not the results can be divided to give two sets of results corresponding to between-kit and between-batch.
The measurement of between-batch imprecision inevitably involves the storage of specimens over a period of time. The results, therefore, can never be entirely free of influences from the storage process. Specimens may be stored either freeze-dried, frozen, or in liquid form. Each introduces its own variability. Freezing and maintaining at -20 0 is one of the most commonly used methods, but some constituents, such as the more labile enzymes, can become inactivated to a degree that is quite variable from sample to sample. Similarly, maintenance in the liquid form at 4 0 for a few days can result in a loss in activity of some constituents. This scheme, therefore, recommends the use of two methods for determining between-batch imprecision. Each method has its own uncertainties, although systematic changes are allowed for, but by using both methods it is hoped that gross effects caused by storage can be identified.
Detailed methods for measuring imprecision. At least three specimens of material should be obtained with concentrations of analyte at suitable levels and of sufficient quantity for at least 40 estimations. The specimens should preferably be of the fluid for which the kit is designed, and the concentrations should cover the analytical range of the kit and include clinically significant levels.
Within-batch precision. Each specimen should be assayed at least 20 times in one batch. When the kit is designed for single tests, at least 20 bottles of reagent should be reconstituted and the contents carefully mixed to produce a single solution. The specimens should be analysed 20 times with this bulked solution in addition to 20 analyses with 20 individual bottles of reagent. In this way variations caused by technique can be separated from those caused by bottle-to-bottle variations in the reagent.
Between-batch precision. At least 20 samples of these specimens (or others of similar composition) should be stored frozen at -20 0 or thereabouts and analysed in successive batches. If the same reagents are being used for more than one batch, a suitable freeze-dried control serum (or other appropriate control material) should be included in each batch to differentiate instability of the specimen from instability of the reagent. These batches should be run at regular intervals (for example, one per day), and the time (in days) at which they were done should be recorded.
Samples from each run should be kept at approximately 4 0 and rerun with the next batch. 139 Accuracy Accuracy is very difficult to assess. By definition (IFCC, 1976) it refers to the conformity ofresults to the true result which, in many cases, cannot be determined. When the analyte is available in a purified form in sufficient quantities to be weighed, solutions of known weight composition can be prepared and these figures used as the true values. When the analyte is not available pure, it is possible only to compare the results from the kit with those obtained by a reference method. In these circumstances it is essential to realise that both the kit and the reference method are subject to imprecision, and it is important to use statistical methods that allow for this fact. It is essential that the imprecision of the reference method is known, and it is useful if its inaccuracy is also known. This scheme makes recommendations for when pure analyte is available and when it is not.
Pure analyte is available. Suitable standard solutions of the pure analyte in water, or other suitable fluid (for example, physiological saline), should be prepared by accurate weighing. The analyte must be dry and weighed in sufficient quantity to ensure 0'1 %accuracy. It should be dissolved in the solvent and the solution diluted in grade A volumetric glassware to a volume of at least 50 ml (or in grade B glassware to at least 100 ml), Solutions of various concentrations may be prepared by dilution of a single stock solution of high concentration. At least five such solutions covering the range of the kit should be analysed in triplicate. The solutions should have concentrations spread fairly evenly across the range of the kit, and, where appropriate, a sixth specimen may be included just beyond the range in order to assess how the kit performs in these circumstances.
If the source fluid for which the kit is designed can be prepared or obtained free of the analyte, a similar series of solutions to those described in the above paragraph should be made in this fluid, and analysed in triplicate.
If the source fluid cannot be obtained free of the analyte, a suitable pool of low value should be analysed 10 times and the mean calculated. Standard solutions of the analyte in this fluid can now be prepared and analysed in triplicate.
Comparative studies using an established technique should be carried out as described below.
Pure analyte is not available. This includes all enzymes and any analyte for which results are not expressed in weight terms.
A comparison technique must be available. This should preferably be an internationally recognised reference technique, but if one is not available, the comparison technique should be a commonly used and understood technique. The report must contain details of this technique.
A specimen that contains a high level of the analyte and another containing a low or zero level should be obtained. These two specimens should be analysed 10 times each by the reference method and then mixed volumetrically or by weight to yield a series of at least five specimens of known relative concentrations covering the analytical range of the kit. These specimens should be analysed in triplicate by each method.
A similar series of solutions should be prepared in which water, or a suitable simple aqueous solution (for example, physiological saline), is used as diluent; these should be analysed in triplicate by each method.
Random specimens should also be analysed by each technique, but care should be taken that these are spread fairly evenly throughout the analytical range.
Where a suitable international or national reference preparation exists, this should be included in [he above experiments either as a single specimen or as the material from which all the specimens are made.
Stability
It may be impracticable in many instances to assess the stability of kits in the packaged form, but, if practicable, tests similar to, but less extensive than, those described above should be carried out at known times just after expiry of the kit in order to indicate in what way the results deteriorate when the kit is old.
Reconstituted reagents should be used to assay the same specimens through and beyond their stated usable life. Care must be taken to ensure that it is the deterioration of the reagents and not of the specimens which is being monitored. A suitable way of doing this would be to include a freshly reconstituted freeze-dried control serum with each batch of specimens.
Interferences
When materials that may be present normally or in pathological conditions in the source fluid are known or suspected to interfere with the analytical method, this interference should be assessed at clinically significant concentrations of the analyte. Two solutions should be prepared in the source fluid of the analyte at a clinically significant level, one containing zero and another a high pathological concentration ot the interfering substance. Each solution should be analysed at least in triplicate. If any significant difference is observed between the two solutions, solutions with intermediate concentrations of the
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interfering substance should be prepared and· analysed. A graph may then be drawn of the apparent analyte concentration (ordinate) plotted against the concentration of interfering material (abscissa) from which the linearity of the interference may be deduced. If linearity is observed, the concentration of the interfering substance that gives a 10% change (positive or negative) in apparent analyte concentration should be recorded. This scheme is not concerned with interferences that occur because of effects in vivo.
Qualitative tests
Some diagnostic products are designed merely to detect the presence of a material or to provide quantitative information only in discrete steps. Various test strips for urine analysis fall into this category. Testing of these products can involve only an assessment of the concentration at which the test becomes positive or moves from one positive level to another. In addition, the evaluator should give at least a subjective impression of how sharply defined the transition is.
A series of solutions should be prepared with suitable small increments of concentration across each concentration at which the test is expected to move from one category to the next (for example, negative to positive, + to + +, etc). These solutions must be made in the fluid which the system is designed to assay. In most cases fluid free of the analyte can probably be obtained along with pure analyte, If this is not so, samples with high and low levels should be analysed by some quantitative technique and mixed to produce suitable intermediate mixtures.
Each solution should then be tested with the test system and the result recorded along with a subjective comment where appropriate. These comments should enable the evaluator to give a subjective comment on the sharpness of the transition and the likelihood of obtaining an equivocal result.
Studies of interference can be conducted along the lines suggested above.
RESULTS
It is important that the results of an evaluation are presented in a way that is readily interpreted by the reader. It is also important that the presentation of results by different evaluators are presented in a sufficiently standard way so that the performance of similar products evaluated by different analysts may readily be compared. This section recommends such a standard presentation. Reference is made to the statistical equations which will be found on page 144.
Outliers
In any evaluation process in which a specimen is being analysed many times, occasionally a single result will be obtained that lies a long way from the mean value. The detection of these 'outliers' is an important part of the evaluation process, and some decision has to be made concerning the most probable cause. If the cause is a malfunction of the instrument being used, this result should be eliminated from the statistical processes, since it is not a part of the population being sampled by the other results. However, frequently it will not be possible a priori to establish the cause of the discrepancy. In the case of kits designed for single tests it is never possible to eliminate for certain the kit as the source of the discrepancy. In other cases, however, it is difficult to understand how a reagent system that has performed several tests quite successfully suddenly produces a wildly discordant result followed by more consistent ones. It is much more likely that there has been a transcription error or a malfunction of some other part of the system (specimen, sampling, or instrumentation). In these circumstances it is considered that, when the chance that an outlier is truly a reflection of random fluctuation around the mean value becomes very small, it is right to eliminate this outlier from the statistical analysis and to report its occurrence elsewhere in the report. In the case of single-test systems it is even more important to draw attention to the fact that outliers have occurred. They may still be caused by factors not connected with the kit, but nevertheless the possibility of a faulty reagent system cannot be discounted. The fact remains, however, that the chances that the outlier is due to chance random variations about the mean is very small, and therefore the chance that it is due to a malfunction or to a bad bottle of reagent is large. It is therefore recommended that even in the evaluation of single-test kits such outliers are eliminated from the statistical analysis and reported and discussed elsewhere in the report.
It is recommended above that measurements of imprecision are made on 20 replicate measurements. Assuming a normal distribution, the chances of one result out of 20 falling more than three standard deviations from the mean is about 5 %. This is rather too high a probability to justify elimination of such a result. When the confidence limits of the standard deviation including this result are calculated, they include the best estimate of the standard deviation obtained when this result is excluded. It cannot, therefore, be said that such an outlier is having a significant effect on the results. If, however, a single result is four standard deviations from the mean, the 95 % confidence limits of the standard deviation calculated with this result included now exclude the 141 best estimate of the standard deviation calculated from the other 19 results. Since the probability that this result is genuinely caused by random fluctuation about the mean is only 0'12%, it is recommended that any result falling at or beyond four standard deviations from the mean is considered an outlier, eliminated from the statistical analysis, and reported separately.
Precision
Within-batch prectston. The results from each specimen in the experiments described on page 138 are used to calculate a mean and a standard deviation by the use of equations 4 and 5. Any result that is more than four standard deviations from the mean is eliminated, and the mean, standard deviation, and coefficient of variation are recalculated. If any result is eliminated for this reason the actual value obtained should be reported. Finally, the 95 % confidence limits of the mean and the standard deviation should be calculated from equations 7 and 8.
When reagent has been bulked together from several bottles of a single-test kit, any change in the mean value compared with the individual tests should be ignored. Any apparent difference in imprecision can be assessed for significance by the methods described on page 143.
Between-batch precision. This has been determined in two ways.
1 Specimens kept frozen, for example, and analysed in successive batches. These results, y, together with the time, in days, at which they were determined are substituted into equation 9. The value of s so determined is the between-batch standard deviation allowing for any drift that may have occurred during the period of the evaluation. The mean value is calculated from equation 4, and the coefficient of variation is calculated from equation 6, substituting s for a. The confidence limits of the standard deviation are calculated from equation 10. If it is desired to assess the significance of any apparent drift, this may be done by evaluating t from equation 11 and comparing this with the figures given in a table of the two-tailed Student t distribution with (n -2) degrees of freedom. If the calculated figure exceeds the tabulated figure, the drift is significant.
2 Specimens maintained at 4 0 and reanalysed in the next batch. The result from the second batch is subtracted from that from the first, and these differences are substituted into equations 4, 5, and 7. The between-batch standard deviation is the value of a from equation 5 divided by 1·414. If the limits deduced from equation 7 enclose zero, there is no significant change in the analytical result after storage for one day. Substitution of SIIII/2 into equation 8 in place of S1I1I yields the confidence limits of the standard deviation.
Accuracy and linearity
The difference between the largest and smallest result from the triplicate analyses should be divided by the within-batch standard deviation. If the result exceeds four the analysis should be repeated.
Linearity can be shown satisfactorily only by means of graphs. The means of the triplicate measurements are plotted (ordinate) against the relative concentrations deduced from the volumetric or gravimetric dilutions (abscissa). Error bars equal to 2'la/~r; where a is the within-batch standard deviation, should be added to the points in the ordinate direction. If a single straight line cannot be made to pass through all the error bars, only those points through which a straight line can be made to pass should be used in the subsequent analysis.
Accuracy is best indicated statistically by means of the coefficients of the least-squares regression line relating the analytical result (y) to the true or the reference-method result (x). Only those points within the range judged to be linear should be included, and the correct equations to use depend upon whether pure analyte is available (and hence true values are known) or not. When comparisons are being made the reference-method results (abscissa) cannot be assumed to be exact, and allowance must be made for their imprecision. The slope of the resulting regression line indicates any bias that is proportional to the concentration of the analyte; the intercept indicates any constant bias. Although graphical representation of comparative results is useful it is not essential. The regression parameters with their confidence limits contain the relevant information. However, when methods are being compared, the confidence limits of the intercept cannot be calculated. Therefore in these circumstances graphs will be helpful, especially if many comparative results have been obtained on unknown specimens. Error bars showing 95 % confidence limits in both directions should be shown on a sufficient number of points to enable the reader to assess the imprecision of the two methods throughout the range.
If pure analyte is available the value of x is known precisely. When the imprecision of the kit method is independent of the concentration of analyte, analytical results, y, and the corresponding true values, x, can be inserted directly into equations 12 and 13 to obtain estimates of the slope and intercept of the regression line. Equations 14 and 15 yield the corresponding confidence limits. However, imprecision is seldom independent of concentration,
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and it was the purpose of the within-batch measurements of imprecision (see above) to evaluate this. From these results one can estimate the expected standard deviations, a, at each value of y, and these are used to calculate a series of weighting factors, w, given by equation 16. Each of these is divided by the mean value of w to give a series of factors, f, one at each value of y. All values of x, x 2 , y, xy are multiplied by the corresponding value of f before being inserted into equations 1 to 3 for evaluation of equations 12 to 15.
If pure analyte is not available the true values of concentration are not known and have had to be estimated by means of a reference method. Variability is therefore present on both axes of the regression, and this must be allowed for. The imprecision of the kit method is known from the experiments on page 138. The same information is required for the reference method. The ratio, A, of the variance of the kit method to that of the reference method is calculated from equation 17.
It has to be assumed that this ratio is independent of the concentration of analyte, and this assumption is likely to be at least approximately true. This ratio, together with the summations of equations 1 to 3, are inserted into equations 18 and 13 to yield estimates of the slope and intercept. The confidence limits of the slope are given by equation 19; complex as this appears it is readily evaluated with a mathematical hand calculator. The confidence limits of the intercept cannot be determined in these circumstances.
Stability
Measurements of the imprecision and inaccuracy of an out-of-date kit should be obtained in exactly the same way as described above. The results of the analyses during the life of reconstituted reagents should be shown graphically along with the results from the control material. The analytical results should be shown as a percentage of the initial value on the ordinate and time on the abscissa.
Interferences
If the interference is linear, the concentration resulting in a 10 % change in apparent concentration of analyte is adequate indication, but otherwise the results should be shown graphically (seepage 140).
Qualitative tests
Since these systems are designed for subjective assessment, this is the only meaningful way of evaluating them. The evaluator should give his subjective impressions along with the results of his tests, as described on page 140.
Conclusions

SUBJECTIVE COMMENTS
Although the results of an evaluation must be presented in a form that enables the reader to decide for himself whether or not the product will be adequate for his purposes, the evaluator should give a subjective opinion as to whether or not the results of the evaluation indicate that the kit is suitable for the clinical laboratory. He should also give an opinion of the convenience of the kit in use. The remainder of this section will be concerned with recommendations on the methods to be used when comparing two or more products for the same assay. In general, no result can be said to be different (at the 5% level of confidence) from any value enclosed by its 95 % confidence limits. However, two results whose confidence limits overlap may still be significantly different. Similarly, a series of results, none of which is in itself significant, may together add up to significance. PRECISION Estimates of imprecision from relatively small numbers of determinations are not themselves very precise. Therefore even quite large differences between different products may not be significantly different. Significance may be tested by means of the F statistic given by equation 20, in which A represents the set having the higher standard deviation and B the set having the lower value (that is, F is always greater than unity). This value of Fiscompared with that given in a table of the upper 2·5% points of the F statistic in the column for (nl)A and the row for (n -1)B, where n is the number of samples used for the estimate of imprecision (for n = 20, F = 2'53).
It must not be forgotten that the within-batch imprecision has virtually no implications for the kit except in as much as a sensitive assay. requiring a smaller sample volume. may show worse precision than a less sensitive method, using a larger volume, because of the greater imprecision involved with smaller samples. Comparisons therefore can only validly be made when the kits are assessed on the same equipment.
The between-batch imprecision includes the within-batch figure, but there is no advantage in trying to separate the two effects. Unless the imprecision of the instrumentation is known independently to be the same between batches as it is within a batch, any change in imprecision between batches compared to within a batch cannot for certain be ascribed to kit-to-kit variation. If more than one batch was assayed with each bottle of reagent, it may be worth separating the results into 143 those done with the same bottle and those done with different bottles and using the F-test to test for significant differences.
Although it may appear that the imprecision of one kit is no different from another when judged by the results of analyses on anyone of several specimens, nevertheless, if there are many of these specimens all indicating the same trend, significance may be achieved. This may be established by treating the individual pairs of imprecision figures (that is, the estimates of the standard deviation obtained from the two kits with each individual specimen) in exactly the same way as the pairs of analytical results were treated (page 141 (Precision». A slightly more rigorous method is to use the Wilcoxon signed rank test. This is a non-parametric test which is described in many text books of statistics and will not be reproduced here.
ACCURACY
Analytical results should have been obtained on three series of diluted specimens:
1 analyte dissolved in water (or other simple fluid) and diluted with water (or simple fluid); 2 analyte dissolved in a biological fluid and diluted with water (or other simple fluid); 3 analyte dissolved in a biological fluid and diluted with that fluid. The linearity graphs of these three systems can be used to deduce useful information concerning the specificity of the test system and to detect possible interfering substances in the source fluid.
Assays of the analyte in water will reveal any fundamental faults in the assay itself, although in some instances it may reveal effects such as association equilibria in the analyte itself that affect its assay. Only a detailed examination of the analyte and the chemistry of the analytical system can reveal this, and such work is outside the scope of an evaluation. In general, this set of assays should give a linear graph passing through the origin and of unit slope. Absence of linearity may be caused by association equilibria in the analyte but is more likely to be caused by such things as inadequate concentrations of indicator enzymes in enzymelinked assays. Failure of the graph to pass through the origin indicates inadequate blanking or, in kinetic assays, spontaneous reactions of some kind. A slope other than unity indicates inadequate calibration.
Assays of the analyte in the biological fluid diluted with water may reveal non-specificity or interfering materials present in the biological fluid. The former is indicated by a slope that is different from that obtained with pure aqueous solutions. Interfering compounds may also give rise to a change in slope but may also give rise to non-linearity. Both effects may be positive or negative, giving rise to slopes greater than or less than unity and curvature concave or convex to the x-axis. The curves should still pass through the origin unless the blanking has been inadequate. When assessing slopes that are not unity in systems where pure analyte could not be added to fluid free of the analyte, care must be taken because one is depending upon an analytical measurement (albeit the mean of 10 measurements) to set the scale of the x-axis. Some error is inevitable and would affect the apparent slope of the regression line.
When the analyte is dissolved in a biological fluid and diluted with that fluid, departures of the response from linear with a slope of unity and an intercept of zero may be caused by a combination of the effects discussed above. Also non-specificity may appear as an intercept that is not zero and/or as a slope not equal to unity, depending upon the relative concentrations of the non-specific-reacting material in the two fluids used to prepare the solutions. Similar departures of slope and intercept from their ideal values may result from errors in the analytical determination of the concentrations of the analyte in the fluids from which the specimens were made. This is especially true if the reference technique used is also not specific. Unfortunately, the situation can be sufficiently complicated that in general no very definite conclusions can be drawn.
In comparing the inaccuracy of two kits, or a single kit with the reference method, one will wish to compare mean values on replicate assays of the same specimen, and also the regression coefficients.
If the standard deviations of the two sets of results are not significantly different, an observed value of t may be calculated from equation 21. If this value is greater than that given in a table of the Student t-distribution for (n + m -2) degrees of freedom and p = 0'05, the means are significantly different. If the standard deviations are different, though not significantly so, a mean value may be calculated from equation 22 for substitution in equation 21.
If the standard deviations of the two sets do differ significantly, then the two mean values, the two standard deviations, and a quantity 8 given by equation 23 are inserted into equation 24 to obtain an observed value of the Fisher-Behrens statistic which is compared with tabulated values. If the observed value is greater than the tabulated value the means are significantly different.
When the values of x are known exactly, two regression slopes may be compared by calculating their standard errors from equation 25 and substituting these together with the best estimates of the P. H.Lloyd slopes in expression 26. If the resulting number is. greater than 1'96, the slopes are significantly different.
When the values of x are not known exactly, this. procedure is not applicable. The best method of estimating the similarity of the response is to plot the results from the two kits against one another and test the slope of the resulting line for unity by means of equation 19.
When the values of x are known exactly, the regression intercepts may be compared by calculating their standard errors from equation 27, and substituting these in expression 28. If the resulting number is greater than 1·96 the intercepts are significantly different. When the values of x are not known exactly there is no way of testing the significance of any difference observed.
STABILITY
If the analytical results on specimens follow those of the control material as the reagent ages, one may confidently say that the reagent is deteriorating in some way. If, however, the two sets of results do not change together, care must be taken over the interpretation since deterioration of the specimens may be contributing to the overall picture. The significance of any change observed should be assessed in terms of the manufacturer's claim for the stability of his product and the clinical significance of the changes observed.
INTERFERENCES
The results of any interference studies should be assessed in terms of the clinical implications in cases where the interfering substance is likely to be present.
Statistical equations
This section contains the equations referred to in the foregoing text. Certain simplifications are used in the mathematical notation in order to simplify the equations. These together with definitions of the terms used are given below. n is the number of observations in a set.
m is the number of observations in a second set when comparisons are being made. y is used as the general symbol for an analytical result obtained with a kit.
x is used in general as the independent variable in regression analyses. It may represent time, true analytical value, or the analytical result from a reference method. X, 1 are the mean values of x, y respectively, a is the estimate of the standard deviation, defined in equation 5. s.; Syy, S",y, s are defined by equations 1, 2, 3, and 9
respectively. t is the Student t statistic. b is the estimate of the slope of a regression line relating two variables. a is the estimate of the intercept of the regression lineatx = O. w is a weighting factor defined by equation 16. Ais the ratio of variances defined by equation 17.
A, B are used as subscripts to distinguish parameters derived from two different groups of observations when making comparisons. F is the F statistic. II is the number of degrees of freedom. X 2 is the chi-squared statistic. Values are taken from the tables in a symmetrical way. For example, to obtain 95 % confidence limits, values of X 2 are taken at the 97'5% and 2'5% points of the distribution. 
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